Research

Working in partnership with leading experts, our digital hypnotherapy programs are grounded in rigorous research that drives our mission to fuel the transformation of health and well-being.
Our research partners

Research outcomes

Built on clinical evidence, our digital hypnotherapy programs leverage research to offer patients essential support and tools that promote transformative, lasting change.

Irritable Bowel Syndrome

81%
Of the 71% of patients who responded to hypnotherapy, 81% maintained their improvements over time.

Smoking cessation

72%
72% of Finito users report stopping or reducing their smoking after completing the program.

Hot flashes

70-80%
Clinical trials have shown that hypnotherapy can help reduce hot flashes by 70-80%.

Research studies

Our hypnotherapy programs were all developed from these studies in IBS, menopause, smoking cessation, and mental health.
Filter by
Hot flashes
Menopause
App delivered
Retrospective
Gut-directed hypnotherapy
Hypnotherapy
IBS
RCT
Low FODMAP
Showing
X
of
Y
studies

Randomised clinical trial: The efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome

S. L. Peters, C. K. Yao, H. Philpott, G. W. Yelland, J. G. Muir, P. R. Gibson
RCT
IBS
Low FODMAP
Hypnotherapy
Gut-directed hypnotherapy
  • Durable effects of gut-directed hypnotherapy are similar to those of the low FODMAP diet for relief of gastrointestinal symptoms.
  • Hypnotherapy has superior efficacy to the diet on psychological indices.
Read the full study →

Smartphone app-delivered gut-directed hypnotherapy improves symptoms of self-reported irritable bowel syndrome: A retrospective evaluation

Simone L. Peters, Peter R. Gibson, Emma P. Halmos
Retrospective
IBS
Hypnotherapy
App delivered
Gut-directed hypnotherapy
  • Completion of gut-directed hypnotherapy via an app-delivered program appears to have a response rate similar to that reported for face-to-face therapy without apparent adverse effects.
Read the full study →

Mobile app-delivered gut-directed hypnotherapy significantly improves symptoms of irritable bowel syndrome. Is this the way of the future?

Simone L. Peters, Peter R. Gibson, Emma P. Halmos
IBS
Hypnotherapy
App delivered
Gut-directed hypnotherapy
  • Mobile app-delivered gut-directed hypnotherapy significantly improved overall and specific symptoms of IBS similar to rates seen in face-to-face trials.
  • IBS patients who respond poorly to medications may respond better.
  • Mobile app-delivered gut-directed hypnotherapy may provide a cost-effective and accessible alternative to otherwise expensive treatment and enable the widespread use of the treatment, despite limited numbers of trained professionals.
Read the full abstract →

App-delivered gut-directed hypnotherapy program Nerva improves symptoms in patients with irritable bowel syndrome but how can we ensure users are compliant?

Simone L. Peters, Peter R. Gibson, Emma P. Halmos
IBS
Hypnotherapy
App delivered
Gut-directed hypnotherapy
  • App-delivered gut-directed hypnotherapy improves overall and individual gastrointestinal symptoms.
  • Users who complete the program report greater improvement in psychological outcomes.
  • Healthcare practitioner referral is a positive predictor of program completion, but it does not alter rates of efficacy.
Read the full study →

Clinical hypnosis in the treatment of postmenopausal hot flashes: A randomized controlled trial

Gary R Elkins, William I Fisher, Aimee K Johnson, Janet S Carpenter, Timothy Z Keith
RCT
Hypnotherapy
Menopause
Hot flashes
  • Compared with structured-attention control, clinical hypnosis results in significant reductions in self-reported and physiologically measured hot flashes and hot flash scores in postmenopausal women.
Read the full study →

Self-hypnosis for sleep disturbances in menopausal women

Julie L Otte, Janet S Carpenter, Lynae Roberts, Gary R Elkins
Hypnotherapy
Menopause
  • There was a significant reduction of poor sleep quality in all groups with a significant increase in minutes slept in all groups. The majority of women also showed clinical improvements in duration.
  • There were clinically meaningful improvements in reducing the perception of poor sleep quality in 50-77% of women across time. Overall, the use of self-hypnosis as a treatment program for sleep problems related to menopause was acceptable for women.
Read the full study →

App-delivered gut-directed hypnotherapy halves the longterm costs associated with managing Irritable Bowel Syndrome (IBS) symptoms and improves work productivity

Simone L. Peters, Peter R. Gibson, Emma P. Halmos
IBS
Gut-directed hypnotherapy
Hypnotherapy
  • Money spent on managing IBS symptoms reduced significantly for Nerva app users after the 6 week program and remained stable at 6-months.
  • Nerva users reported significant long-term improvements in absenteeism, presenteeism, work productivity loss and impairment in preforming daily activities post program completion.
Read the full study →
Show more

Scientific Advisory Board

Dr. Michael Yapko

Award winning psychologist, author and clinical hypnosis expert.

Dr. Irving Kirsch

Associate Director of the Program in Placebo Studies and Lecturer in Medicine at Harvard Medical School.

Dr. Simone Peters

Psychophysiologist & Gut-Directed Hypnotherapist at Monash University

Dr. Gary Elkins

Professor, Psychology and Neuroscience at Baylor University.

Submit a research proposal

We’re looking for research collaborators who are interested in topics such as IBS, smoking cessation, menopause, chronic pain, sleep, and more.
Submit your research proposal here.
Hypnotherapy

Nerva

Irritable bowel syndrome

Evia

Menopause & hot flashes

Finito

Smoking cessation
Platform

Clinicians

Patient management & clinician education

Matter

Mind-focused education
Resources
Support & ContactPrivacy & TermsCareersPartnerFind a ClinicianPress Kit
Copyright 2022 Mindset Health Pty Ltd ABN 11 617 368 957
TermsPrivacyData collection policy
*Disclaimer: Nerva, Evia & Finito are self-management & well-being tools for medically-diagnosed irritable bowel syndrome (IBS), menopause and smoking habits. Nerva, Evia & Finito have not been cleared or approved by the U.S. Food and Drug Administration (FDA), or Therapeutic Goods Administration or equivalent. Nerva, Evia & Finito are not intended as a treatment or to provide medical advice and do not replace care by your provider and existing treatments you may be using. You should continue to take your medications as directed by your healthcare provider and should always seek the advice of your healthcare provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen. Never disregard professional medical advice or delay seeking it. If you have any feelings or thoughts of harming yourself or others, please dial 911 (or local equivalent) or go to the nearest emergency room.